Literature DB >> 27882192

Next-Generation Antibody-Drug Conjugates (ADCs) for Cancer Therapy.

Jagath Reddy Junutula1, Hans-Peter Gerber2.   

Abstract

Entities:  

Year:  2016        PMID： 27882192      PMCID： PMC5108033          DOI： 10.1021/acsmedchemlett.6b00421

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  8 in total

Review 1.  Combining antibody-drug conjugates and immune-mediated cancer therapy: What to expect?

Authors:  Hans-Peter Gerber; Puja Sapra; Frank Loganzo; Chad May
Journal:  Biochem Pharmacol       Date:  2015-12-11       Impact factor: 5.858

2.  Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.

Authors:  Jagath R Junutula; Helga Raab; Suzanna Clark; Sunil Bhakta; Douglas D Leipold; Sylvia Weir; Yvonne Chen; Michelle Simpson; Siao Ping Tsai; Mark S Dennis; Yanmei Lu; Y Gloria Meng; Carl Ng; Jihong Yang; Chien C Lee; Eileen Duenas; Jeffrey Gorrell; Viswanatham Katta; Amy Kim; Kevin McDorman; Kelly Flagella; Rayna Venook; Sarajane Ross; Susan D Spencer; Wai Lee Wong; Henry B Lowman; Richard Vandlen; Mark X Sliwkowski; Richard H Scheller; Paul Polakis; William Mallet
Journal:  Nat Biotechnol       Date:  2008-07-20       Impact factor: 54.908

Review 3.  The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics.

Authors:  Hans-Peter Gerber; Frank E Koehn; Robert T Abraham
Journal:  Nat Prod Rep       Date:  2013-05       Impact factor: 13.423

Review 4.  Antibody-drug conjugates in cancer therapy.

Authors:  Eric L Sievers; Peter D Senter
Journal:  Annu Rev Med       Date:  2012-10-03       Impact factor: 13.739

Review 5.  Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development.

Authors:  Paresh Agarwal; Carolyn R Bertozzi
Journal:  Bioconjug Chem       Date:  2015-01-30       Impact factor: 4.774

Review 6.  Site-specific antibody drug conjugates for cancer therapy.

Authors:  Siler Panowski; Sunil Bhakta; Helga Raab; Paul Polakis; Jagath R Junutula
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

7.  Immuno-oncology combinations: raising the tail of the survival curve.

Authors:  Samuel J Harris; Jessica Brown; Juanita Lopez; Timothy A Yap
Journal:  Cancer Biol Med       Date:  2016-06       Impact factor: 4.248

Review 8.  Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates.

Authors:  Heather Donaghy
Journal:  MAbs       Date:  2016-04-05       Impact factor: 5.857
  8 in total
  5 in total

1.  Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugates.

Authors:  Thomas Botzanowski; Stéphane Erb; Oscar Hernandez-Alba; Anthony Ehkirch; Olivier Colas; Elsa Wagner-Rousset; David Rabuka; Alain Beck; Penelope M Drake; Sarah Cianférani
Journal:  MAbs       Date:  2017-04-13       Impact factor: 5.857

Review 2.  Glycoengineering of Antibodies for Modulating Functions.

Authors:  Lai-Xi Wang; Xin Tong; Chao Li; John P Giddens; Tiezheng Li
Journal:  Annu Rev Biochem       Date:  2019-03-27       Impact factor: 23.643

3.  Shortwave-infrared (SWIR) emitting annexin V for high-contrast fluorescence molecular imaging of tumor apoptosis in living mice.

Authors:  Mahadeva M M Swamy; Setsuko Tsuboi; Yuta Murai; Kenji Monde; Takashi Jin
Journal:  RSC Adv       Date:  2022-07-06       Impact factor: 4.036

4.  CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia.

Authors:  Ying-Ping Jiang; Bob Y Liu; Quan Zheng; Swapna Panuganti; Ruoying Chen; Jianyu Zhu; Madhavi Mishra; Jianqing Huang; Trang Dao-Pick; Sharmili Roy; XiaoXian Zhao; Jeffrey Lin; Gautam Banik; Eric D Hsi; Ramkumar Mandalam; Jagath R Junutula
Journal:  Blood Adv       Date:  2018-07-24

5.  In Vitro and In Vivo Fluorescence Imaging of Antibody-Drug Conjugate-Induced Tumor Apoptosis Using Annexin V-EGFP Conjugated Quantum Dots.

Authors:  Setsuko Tsuboi; Takashi Jin
Journal:  ACS Omega       Date:  2022-01-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.